High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility

• 2024

  Sign in to bookmark this resource.

  Sign in
• Richelle Homo; Andrew Groberg; Megan Donahue; Dustin Halverson; Anna Wooten; Adharsh Ponnapakkam
PMID: 38876155DOI: https://dx.doi.org/10.1016/j.jpeds.2024.114144

---

Access Resources

• Journal ArticleEN

About

This article discusses a study on the use of nirsevimab for infants and an RSV vaccine for pregnant women at a military hospital. It found that over 85% of eligible patients received these treatments from October 2023 to February 2024. The high uptake suggests that such measures can be effective in preventing respiratory syncytial virus (RSV) during birth hospitalizations. This information could help health systems plan better for future RSV seasons, ensuring more newborns are protected against this virus. The authors report no conflicts of interest in their research findings.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Antiviral Agents; Hospitalization; Infant, Newborn; Military Medicine; Military Personnel; Neonatology; Pregnancy; Pregnant Women; Respiratory Syncytial Virus Infections; Vaccination; Respiratory Syncytial Virus Vaccines; Antibodies, Monoclonal, Humanized

Institutions: Brooke Army Medical Center

---

More like this

Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper 2018 · Johns Hopkins University, National Center for Ethics in Health Care, U.S. Department of Veterans Affairs, University of California –San Diego School of Medicine, University of California, San Diego, Virginia Mason Medical Center The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access 2024 · University Medical Center Utrecht, Yenepoya University, University of Edinburgh, National Institutes of Health (NIH), London School of Hygiene and Tropical Medicine Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season 2025 · Beth Israel Deaconess Medical Center, Harvard Medical School

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---